We could not find any results for:
Make sure your spelling is correct or try broadening your search.
L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - MSCL Canada NewsWire TORONTO, le 17 déc. 2024 TORONTO, le 17 déc. 2024 /CNW/...
Canadian Investment Regulatory Organization Trade Resumption - MSCL Canada NewsWire TORONTO, Dec. 17, 2024 TORONTO, Dec. 17, 2024 /CNW/ - Trading resumes in: Company: Satellos Bioscience...
Suspension de la négociation par l'Organisme canadien de réglementation des investissements - MSCL Canada NewsWire TORONTO, le 16 déc. 2024 TORONTO, le 16 déc. 2024 /CNW/...
Canadian Investment Regulatory Organization Trading Halt - MSCL Canada NewsWire TORONTO, Dec. 16, 2024 TORONTO, Dec. 16, 2024 /CNW/ - The following issues have been halted by CIRO: Company:...
- Marks successful completion of full enrollment of SAD cohorts and the first two MAD cohorts in the healthy volunteer study - Up to 10 adult participants with genetically confirmed Duchenne...
Satellos Bioscience Inc. (TSX:MSCL, OTCQB:MSCLF) (“Satellos”), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and...
Satellos Bioscience Inc. (TSX:MSCL, OTCQB:MSCLF) ("Satellos" or the "Company"), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...
Satellos Bioscience Inc. (TSX: MSCL) (OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...
- Completed enrollment for SAT-3247 in Duchenne muscular dystrophy (DMD) in the first three (of five) single-ascending dose (SAD) cohorts with no safety concerns and initiated enrollment of first...
Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL) (OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.03 | -3.52941176471 | 0.85 | 0.86 | 0.81 | 18314 | 0.83223294 | CS |
4 | -0.01 | -1.20481927711 | 0.83 | 0.89 | 0.81 | 108217 | 0.86499106 | CS |
12 | 0.07 | 9.33333333333 | 0.75 | 1.32 | 0.67 | 147427 | 0.88105912 | CS |
26 | 0.325 | 65.6565656566 | 0.495 | 1.32 | 0.45 | 120964 | 0.75466035 | CS |
52 | 0.2 | 32.2580645161 | 0.62 | 1.32 | 0.38 | 95508 | 0.68848996 | CS |
156 | 0.2 | 32.2580645161 | 0.62 | 1.32 | 0.38 | 95508 | 0.68848996 | CS |
260 | 0.2 | 32.2580645161 | 0.62 | 1.32 | 0.38 | 95508 | 0.68848996 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions